NCT02620410View on ClinicalTrials.gov

Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System (RELAX-OAB)

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

January 31, 2022

Conditions
Overactive Bladder
Interventions
DEVICE

Axonics Sacral Neuromodulation (SNM) System

The implantable components of the Axonics Sacral Neuromodulation (SNM) System consist of an IPG and tined lead. Additional components include a clinician programmer, surgical tool kit, recharging kit, and patient remote control.

Trial Locations (6)

Unknown

UZ Leuven, Leuven

Hospices Civils de Lyon, Lyon

Chu De Nantes - Hôtel-Dieu, Nantes

Maastricht University Medical Center, Maastricht

Erasmus Medical Center, Rotterdam

University College London Hospital, London

Sponsors

Lead Sponsor

Axonics, Inc.
All Listed Sponsors
lead

Axonics, Inc.

INDUSTRY

NCT02620410 - Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System (RELAX-OAB) | Biotech Hunter | Biotech Hunter